A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

DEACTIVATE by Xenex: Handheld LED Device Can Quickly Disinfect Surfaces in Confined Spaces

February 1

Deactivate is a high-powered, handheld LED device designed to quickly disinfect surfaces in confined spaces.

Xenex is known for its LightStrike™ Germ-Zapping Robots™, which have been deployed by hundreds of healthcare facilities worldwide for no-touch room disinfection. As a result of the COVID-19 pandemic, LightStrike robots are now used in airports, schools, hotels, sports arenas, police stations and correctional facilities, convention centers, and more to quickly disinfect large rooms and areas.

Recognizing the need for targeted disinfection in small spaces and compact areas, Xenex has launched Deactivate, which utilizes high-powered LEDs to create ultraviolet (UV) light proven to deactivate pathogens, including severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus that causes COVID-19. Deactivate does not require warm-up or cool-down time, and does not leave behind any chemical residue. Post-disinfection, the area is immediately available for use.

“Our mission is to stop the pain and suffering caused by infections by destroying the pathogens that cause them. There are many businesses that need targeted, rapid disinfection, especially compact areas like dental exam rooms, ambulances, office cubicles, and cockpits. We wanted to offer an effective technology for disinfecting small spaces that are hard to clean and that’s what Deactivate provides,” said Irene Hahn, senior vice president of sales and marketing for Xenex.

Evidence-based. Testing performed at the Texas Biomedical Research Institute demonstrated that the Deactivate device achieves a 99% level of disinfection against SARS-CoV-2 in 30 seconds at 1 meter, 99% against vegetative bacteria (methicillin-resistant Staphylococcus aureus – also known as MRSA, Escherichia coli – also known as E.coli) in 1 minute at 1 meter, and 99% against bacterial spores in 2 minutes at 1 meter.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy